| ABC DLBCL | Activated B cell-like Diffuse large B-cell lymphoma |
| BCR | B-cell receptor |
| BET | Bromodomain and extra-terminal |
| BTK | Burton tyrosine kinase |
| β-TrCP | Beta-transducing repeat-containing protein |
| CAC | Colitis-associated carcinoma |
| CAF | Cancer-associated fibroblast |
| CLL | Chronic lymphomatic leukemia |
| CNV | Choroid neovascularization |
| COPD | Chronic obstructive pulmonary disease |
| CSN5 | COP9 signalosome 5 |
| CTL | Cytotoxic T-lymphocyte |
| DC | Dendritic cell |
| DEN | Diethylnitrosoamine |
| DMF | Dimethyl fumarate |
| DSB | Double-strand break |
| EGFR | Epidermal growth factor receptor |
| HCC | Hepatocellular carcinoma |
| HNSCC | Head and neck squamous cell carcinoma |
| ICD | Immunogenic cell death |
| IKK | IκB kinase |
| IL-1 | Interleukin-1 |
| iNUB | Inhibitor of NEMO-Ubiquitin binding |
| IκB | Inhibitor of kappa B |
| KD | Kinase domain |
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
| LPS | Lipopolysaccharide |
| LUBAC | Linear ubiquitin chain assembly complex |
| MALT | Mucosa-associated lymphoid tissue |
| MCL | Mantle cell lymphoma |
| MM | Multiple myeloma |
| mTORC | Mammalian target of rapamycin complex |
| NBD | NEMO-binding domain |
| NF-κB | nuclear factor- “kappa-light-chain-enhancer” of activated B-cells |
| NSCLC | Non-small-cell lung carcinoma |
| OV | Oncolytic virus |
| PD/PDL | Programmed death/PD-ligand 1 |
| POC | Proof-of-concept |
| RA | Rheumatoid arthritis |
| RHD | Rel homology domain |
| SCF | S phase kinase-associated protein 1 (SKP1)-cullin 1-F-box protein |
| SCID | Severe combined immunodeficient |
| SDD | Scaffold/dimerization domain |
| SH2 | Src Homology 2 |
| TAM | Tumour-associated macrophage |
| TCR | T-cell receptor |
| TLR | Toll-like receptor |
| TME | Tumour microenvironment |
| TNFα | Tumor necrosis factor-alpha |
| Treg | Regulatory T cells |
| UBC | Ubiquitin-conjugating enzyme |
| ULD | Ubiquitin-like domain |